GlassScriptPhysician profile
Vito Mantese
NPI 1265429567
$1,178.82
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $194 · 2021: $568 · 2022: $85.39.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $255.48 | 2019-2022 | |
| Getinge USA Sales, LLC | $172.91 | 2019-2021 | |
| Penumbra, INC. | $125.00 | 2021 | |
| Medtronic Vascular, INC. | $113.34 | 2019-2020 | |
| Silk Road Medical, INC. | $110.92 | 2019-2021 | |
| Pfizer INC. | $64.66 | 2021 | |
| Baxter Healthcare | $55.92 | 2021-2022 | |
| Smith+Nephew, INC. | $55.89 | 2019-2021 | |
| Medtronic, INC. | $49.02 | 2021 | |
| Bard Peripheral Vascular, INC. | $46.91 | 2019-2020 | |
| Ethicon US, LLC | $33.96 | 2020 | |
| Boston Scientific Corporation | $30.27 | 2019 | |
| Cardiovascular Systems INC. | $23.85 | 2019 | |
| Covidien LP | $23.38 | 2019 | |
| Cardinal Health 200 LLC | $17.31 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$3,370.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vito Mantese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.